Dutasteride scalp injections: the evidence and the trade-offs
Dutasteride mesotherapy injects tiny doses of a DHT-blocking medicine straight into the scalp, aiming for local benefit with fewer whole-body effects. What the meta-analysis and real-world studies report, the patchy hair loss seen in some case series, and how it compares with tablets.
Dutasteride is a prescription medicine that lowers DHT, the hormone that drives pattern hair loss in people who are genetically sensitive to it. As a daily tablet, it is used off-label for hair loss in some countries. In recent years a different way of using it has become popular in aesthetic and hair clinics: injecting tiny doses directly into the scalp, a technique called dutasteride mesotherapy or intralesional dutasteride.
The appeal is easy to see. If the medicine can work locally in the scalp, perhaps fewer people would worry about the whole-body side effects associated with tablets. But injections bring their own trade-offs, and the evidence is still developing. This guide covers how dutasteride works, what the studies on scalp injections report, the side effects that have been described, including patchy hair loss, and how this approach compares with tablets. It is general information, not personal medical advice. For background on the medicine itself, see dutasteride for hair loss.
Short answer
- It is a way of delivering a proven type of medicine. Dutasteride tablets have randomised trial evidence in men; one meta-analysis found they increased hair count more than finasteride, with similar rates of sexual side effects 1.
- The injection evidence is promising but limited. A 2025 systematic review found studies consistently reported better hair density and thickness after intralesional dutasteride, but the studies varied in method, size and follow-up, and large high-quality trials are lacking 2.
- Real-world data suggest it is usually well tolerated. In a retrospective study of 541 patients, pain was the most common side effect and no serious or sexual adverse events were detected 3.
- Patchy hair loss is a recognised risk. Case series describe patches of hair loss at injection sites, and in one series of three women none fully recovered 4 5.
- It is off-label and should be done by a doctor. It is not a replacement for a proper diagnosis, and it does not remove pregnancy-related precautions for women.
How dutasteride works
Testosterone is converted into DHT by an enzyme called 5-alpha reductase. In pattern hair loss, DHT gradually shrinks sensitive hair follicles, so hairs become thinner and shorter over time; see DHT and hair loss. Finasteride blocks one main form of this enzyme. Dutasteride blocks two forms, and lowers DHT more than finasteride does.
A meta-analysis of three trials comparing the two tablets in 576 men found dutasteride produced a greater increase in total hair count and better photographic scores, with no significant difference in libido, erectile or ejaculation problems 1. Dutasteride is approved for prostate enlargement; its use for hair loss is off-label in many countries, including when it is injected. For more on finasteride, see finasteride for hair loss.
What mesotherapy with dutasteride involves
In dutasteride mesotherapy, a doctor injects a dilute solution of dutasteride into the dermis of the thinning areas through many tiny injections, by hand or with a device 6. Concentrations reported in case series are small, for example 0.025 to 0.05 percent in one report 5. Sessions are spaced weeks to months apart. In a large Spanish real-world study, the most common approach in the first year was one session every three months 3.
The solution may also contain other ingredients, such as solvents, preservatives or a local anaesthetic such as lidocaine. These can matter for side effects, as discussed below. See mesotherapy for hair loss for a broader look at scalp injection cocktails.
What the evidence shows
The 2025 systematic review
A 2025 systematic review and meta-analysis searched several databases for studies of adults with androgenetic alopecia treated with intralesional dutasteride 2. It included randomised trials, non-randomised studies and observational studies. The included studies consistently reported improvements in hair density and thickness, with photographs supporting visual improvement. Treatment was generally well tolerated, with mild scalp irritation and no significant systemic effects reported.
However, the authors noted that studies varied in methods, sample size and follow-up length, and that large, high-quality trials are lacking. They described intralesional dutasteride as promising and called for standardised research to confirm the findings.
Real-world practice
A multicentre retrospective study from Spain included 541 patients treated with dutasteride mesotherapy and followed for at least six months 3. In the 86 patients who used mesotherapy alone and could be assessed after one year, most showed clinical improvement, and 33 (38.4 percent) showed marked improvement. Pain was the most frequent side effect, reported by 246 patients (45.5 percent). No serious or sexual adverse events were detected. The authors suggested it may be an option for selected people who want to avoid oral treatment.
Being retrospective, this study did not have a control group, and only a small proportion of patients could be assessed on mesotherapy alone. It shows what happens in practice, but it cannot prove how much of the improvement came from the injections.
The broader injection review
A 2026 systematic review of injectable treatments for androgenetic alopecia found dutasteride was the second most studied agent after vitamin and peptide mixtures, and that the strongest signal of benefit was seen with dutasteride 6. It also stressed small samples, inconsistent protocols and short follow-up, and called for standardised randomised trials.
What this adds up to
Dutasteride mesotherapy has a plausible basis, because the medicine itself is effective as a tablet. The early injection studies are encouraging. But there is not yet strong evidence on how injections compare with tablets, what dose and schedule work best, or what happens over many years.
Side effects and risks
Common and mild
- Pain during injection, reported by nearly half of patients in the real-world study 3.
- Redness, small bumps and headache for a day or two.
- Forehead swelling. A case series described 14 people who developed swelling of the forehead after scalp mesotherapy, mostly in the first two sessions, lasting one to four days and settling with cold compresses. Lidocaine was used in all cases, and minoxidil and dutasteride were also suspected contributors 7.
Patchy hair loss at injection sites
This is the side effect most worth knowing about before starting:
- In an Indian case series, 4 of 15 people developed patchy non-scarring hair loss at injection sites after a single session of dutasteride mesotherapy. The authors suspected additives such as benzyl alcohol and polysiloxane in the formulation 4.
- A 2026 case series from Portugal described three women with pattern hair loss who developed patches of hair loss after dutasteride mesotherapy. One had features of scarring and later needed surgical correction; another had mixed features; the third had persistent patches despite treatment. None fully recovered 5. The authors suggested possible causes including mechanical injury, solvent toxicity, inflammation or infection, and said the complication may be under-recognised.
These reports do not tell how often this happens overall, but they show that the risk is real and not always reversible. Ask the doctor which formulation is used and what is in it besides dutasteride.
Whole-body effects
The goal of injecting dutasteride is to reduce exposure elsewhere in the body, and studies so far report few systemic effects 2 3. Long-term comparative data are limited, though. Dutasteride can harm a developing male fetus, so women who could become pregnant need careful counselling and reliable contraception, and pregnant women should not handle or receive it. Men should also ask about blood donation precautions, which apply to dutasteride tablets.
Injections or tablets?
| Question | Dutasteride tablets | Dutasteride mesotherapy |
|---|---|---|
| Strength of evidence | Randomised trials in men 1 | Smaller, varied studies 2 |
| Frequency | Daily | Every few weeks to months |
| Main concerns | Sexual side effects, mood, pregnancy precautions | Injection pain, swelling, patchy hair loss |
| Whole-body exposure | Higher | Intended to be lower |
| Cost pattern | Ongoing medicine cost | Per-session procedure cost |
Neither option is right for everyone. Some people combine injections with topical or oral minoxidil; see minoxidil. Others choose tablets and avoid injections. A doctor can help weigh these choices against your diagnosis, sex, plans for pregnancy and preferences.
Cost and value
Prices in Malaysia vary by clinic and number of sessions, and this guide does not quote figures. Ask for the cost per session, how many sessions are planned in the first year, and whether follow-up photographs and reviews are included. Compare that with the ongoing cost of tablets and topical treatments.
Life in Malaysia
Some clinics in Malaysia offer dutasteride injections as part of hair packages, sometimes alongside PRP or microneedling. Dutasteride is a prescription medicine, so injections should only be done by a registered doctor 8. Ask what time of day to book, as forehead swelling can appear the next morning; people who wear a tudung or ride a motorcycle may prefer a session before a quieter day. In humid weather, keep the scalp clean and follow the clinic's advice on washing and covering it after injections.
Common myths
- "Injections mean no side effects." Pain, swelling and patchy hair loss have been reported.
- "It's the same as taking tablets, just easier." The evidence base, dosing and risks are different.
- "Women can use it freely because it stays in the scalp." Pregnancy precautions still apply.
- "More sessions give better results." No standard schedule has been proven better.
- "Any clinic can do it the same way." Formulation, concentration and technique vary.
Common mistakes
- Starting injections without a confirmed diagnosis of pattern hair loss.
- Not asking what else is in the solution besides dutasteride.
- Ignoring new patches of thinning after a session.
- Stopping effective treatment while starting injections.
- Skipping baseline photographs.
- Paying for a long package before reviewing progress.
How a doctor assesses hair loss
A doctor will usually ask when hair loss started, about family history, medicines, diet, recent illness, childbirth or stress, and for women, periods and pregnancy plans. A scalp examination, often with a dermatoscope, helps confirm pattern hair loss and rule out inflammation or scarring. Blood tests such as full blood count, ferritin and thyroid function may be suggested. Standardised photographs at baseline and follow-up make it easier to judge results.
Questions to ask your doctor
- Is my hair loss pattern hair loss, and is dutasteride appropriate for me?
- What concentration of dutasteride will be used, and what else is in the solution?
- How many sessions are planned, and how often?
- What side effects should I watch for, including new patches of hair loss?
- What should I do if a patch appears after a session?
- How does this compare with tablets for someone like me?
- Are there pregnancy, contraception or blood donation precautions for me?
- How will progress be measured, and when will it be reviewed?
Bottom line
Dutasteride mesotherapy delivers a DHT-lowering medicine directly into the scalp. Early studies and real-world data are encouraging and suggest it is usually well tolerated, but the evidence is still limited, and case series show that patchy hair loss at injection sites can occur and does not always recover. If you are interested, see a registered doctor, confirm the diagnosis, ask exactly what will be injected, and compare it honestly with tablets and topical options before committing 8.
Frequently asked questions
What is dutasteride mesotherapy?
It is a procedure where a doctor injects very small amounts of dutasteride, a 5-alpha reductase inhibitor that lowers DHT, into the skin of the scalp through many tiny injections, usually every few months.
Does dutasteride mesotherapy work?
A 2025 systematic review reported improvements in hair density and thickness across included studies, but said the studies varied in method, size and follow-up, and that large, high-quality trials are lacking.
Is it safer than dutasteride tablets?
It is intended to reduce whole-body exposure, and studies so far report few systemic effects. However, long-term comparative safety data are limited, and injections bring their own local risks.
What are the side effects?
Pain during injection is the most common. Others include redness, headache and temporary forehead swelling. Some case series describe patchy hair loss at injection sites, and in a few women it did not fully recover.
How often are sessions done?
In a large real-world study, the most common approach in the first year was one session every three months. There is no single agreed schedule.
Can women have dutasteride mesotherapy?
It has been used in women, but dutasteride can harm a male fetus, so women who could become pregnant need careful counselling and reliable contraception. A doctor should decide whether it is suitable.
Is it better than finasteride or minoxidil?
There is not enough comparative evidence to say so. Oral finasteride, oral dutasteride and minoxidil have larger bodies of evidence.
Is dutasteride mesotherapy available in Malaysia?
Some clinics offer it. Dutasteride is a prescription medicine, and injecting it into the scalp is an off-label use, so it should only be done by a registered doctor who explains the product, dose and risks.
Sources
- PubMed. The efficacy and safety of dutasteride compared with finasteride in treating men with androgenetic alopecia: a systematic review and meta-analysis, Clin Interv Aging, 2019. accessed 27 Oct 2026
- PubMed. Effectiveness and Safety of Intralesional Dutasteride in Patients With Androgenic Alopecia: A Systematic Review and Meta-Analysis, J Cosmet Dermatol, 2025. accessed 27 Oct 2026
- PubMed. Mesotherapy With Dutasteride for Androgenetic Alopecia: A Retrospective Study in Real Clinical Practice, J Drugs Dermatol, 2022. accessed 27 Oct 2026
- PubMed. Paradoxical Nonscarring Alopecia Following Mesotherapy with Dutasteride: A Case Series, Int J Trichology, 2025. accessed 27 Oct 2026
- PubMed. Persistent Alopecic Patches Following Dutasteride Mesotherapy for Female Androgenetic Alopecia: A Case Series, J Drugs Dermatol, 2026. accessed 27 Oct 2026
- PubMed. Injectable Therapy for Androgenetic Alopecia: A Systematic Review, Dermatol Surg, 2026. accessed 27 Oct 2026
- PubMed. Frontal edema due to mesotherapy for androgenetic alopecia: A case series, Dermatol Ther, 2022. accessed 27 Oct 2026
- Malaysian Medical Council. Malaysian Medical Council (registered medical practitioners and specialists). accessed 27 Oct 2026
Educational content. Not medical advice.